Verbio SE/€VBK
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Verbio SE
Verbio Vereinigte BioEnergie AG is a renewable energy company operating within the biofuels industry. The company's core business involves the production and supply of biofuels, specifically bioethanol, biodiesel, and biomethane. Verbio was founded in 2006 and is headquartered in Leipzig, Germany. It operates several production facilities across Germany and has expanded its presence to international markets, including North America and Eastern Europe. Verbio's strategic positioning is enhanced by its integrated production approach, utilizing by-products for energy generation, which contributes to both cost efficiency and sustainability initiatives.
- Ticker
- €VBK
- Sector
- Energy
- Primary listing
- XETRA
- Employees
- 1,349
- Headquarters
- Leipzig, Germany
- Website
- www.verbio.de
Verbio SE Metrics
BasicAdvanced
€1.8B
28.05
€1.00
0.06
-
Price and volume
Market cap
€1.8B
Beta
0.06
52-week high
€46.98
52-week low
€14.68
Average daily volume
118K
Financial strength
Current ratio
1.695
Quick ratio
0.726
Long term debt to equity
0.175
Total debt to equity
0.271
Interest coverage (TTM)
14.26%
Profitability
EBITDA (TTM)
175.829
Gross margin (TTM)
17.97%
Net profit margin (TTM)
3.41%
Operating margin (TTM)
6.40%
Effective tax rate (TTM)
47.74%
Revenue per employee (TTM)
€1,390,000
Management effectiveness
Return on assets (TTM)
5.65%
Return on equity (TTM)
8.18%
Valuation
Price to earnings (TTM)
28.05
Price to revenue (TTM)
0.955
Price to book
2.19
Price to tangible book (TTM)
2.19
Price to free cash flow (TTM)
22.931
Free cash flow yield (TTM)
4.36%
Free cash flow per share (TTM)
1.223
Growth
Revenue change (TTM)
18.54%
Earnings per share change (TTM)
-146.10%
3-year revenue growth (CAGR)
-1.65%
10-year revenue growth (CAGR)
11.09%
3-year earnings per share growth (CAGR)
-21.66%
10-year earnings per share growth (CAGR)
2.60%
10-year dividend per share growth (CAGR)
2.92%
What the Analysts think about Verbio SE
Analyst ratings (Buy, Hold, Sell) for Verbio SE stock.
Analyst projections of the future price of Verbio SE stock.
Bulls say / Bears say
Verbio delivered a strong turnaround in FY 2025/26: EBITDA reached €193.9 million, net financial debt fell to about €92 million and it generated positive free cash flow. The board is also proposing a €0.20 dividend per share. (Verbio)
Management expects FY 2026/27 EBITDA of €210–250 million, with growth driven by higher North American output, rising biomethane production and greater greenhouse-gas quota earnings. Lower capital spending is also expected to help reduce net debt further. (Verbio)
Verbio has commissioned a new plant with capacity for up to 60,000 tonnes of bio-based chemicals a year. This gives the group a potential higher-value business beyond fuel markets, using a feedstock it already produces. (Verbio)
The €210–250 million FY 2026/27 EBITDA forecast was below the €266 million analyst consensus, and shares fell 2.3% after the outlook. That suggests the recovery may already be priced for stronger growth than management currently expects. (Reuters)
Part of FY 2025/26 EBITDA benefited from a €19.1 million reversal of write-downs on greenhouse-gas quota inventories and gains from commodity forward contracts. These items make the headline rebound less reliable as a guide to recurring earnings. (Verbio)
The new chemicals plant still faces a commercial ramp-up: customers must qualify its products for their applications, and volumes are expected to build as those applications develop. That leaves uncertainty over how quickly the nearly €100 million investment will generate returns. (Verbio)
Data summarised monthly by Lightyear AI. Last updated on 16 Oct 2026.
Verbio SE Financial Performance
Revenues and expenses
Verbio SE Earnings Performance
Company profitability
Upcoming events
Funds containing Verbio SE
AllEURUSDGBP
Fund name | Fund size | €VBK weighting |
|---|---|---|
iShares TecDAX€EXS2 | €645M | 0.38% |
iShares Global Clean Energy€IQQH | $3.1B | 0.30% |
iShares Global Clean Energy£INRG | $3.1B | 0.30% |
Xtrackers MSCI Europe Small Cap£XXSC | $3.6B | 0.03% |
Xtrackers MSCI Europe Small Cap€DX2J | $3.6B | 0.03% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.